Literature DB >> 27746126

Early matrix metalloproteinase-9 inhibition post-myocardial infarction worsens cardiac dysfunction by delaying inflammation resolution.

Rugmani Padmanabhan Iyer1, Lisandra E de Castro Brás2, Nicolle L Patterson3, Manishabrata Bhowmick4, Elizabeth R Flynn1, Majdouline Asher5, Presley L Cannon1, Kristine Y Deleon-Pennell1, Gregg B Fields6, Merry L Lindsey7.   

Abstract

Matrix metalloproteinase-9 (MMP-9) is robustly elevated in the first week post-myocardial infarction (MI). Targeted deletion of the MMP-9 gene attenuates cardiac remodeling post-MI by reducing macrophage infiltration and collagen accumulation through increased apoptosis and reduced inflammation. In this study, we used a translational experimental design to determine whether selective MMP-9 inhibition early post-MI would be an effective therapeutic strategy in mice. We enrolled male C57BL/6J mice (3-6months old, n=116) for this study. Mice were subjected to coronary artery ligation. Saline or MMP-9 inhibitor (MMP-9i; 0.03μg/day) treatment was initiated at 3h post-MI and the mice were sacrificed at day (D) 1 or 7 post-MI. MMP-9i reduced MMP-9 activity by 31±1% at D1 post-MI (p<0.05 vs saline) and did not affect survival or infarct area. Surprisingly, MMP-9i treatment increased infarct wall thinning and worsened cardiac function at D7 post-MI. While MMP-9i enhanced neutrophil infiltration at D1 and macrophage infiltration at D7 post-MI, CD36 levels were lower in MMP-9i compared to saline, signifying reduced phagocytic potential per macrophage. Escalation and prolongation of the inflammatory response at D7 post-MI in the MMP-9i group was evident by increased expression of 18 pro-inflammatory cytokines (all p<0.05). MMP-9i reduced cleaved caspase 3 levels at D7 post-MI, consistent with reduced apoptosis and defective inflammation resolution. Because MMP-9i effects on inflammatory cells were significantly different from previously observed MMP-9 null mechanisms, we evaluated pre-MI (baseline) systemic differences between C57BL/6J and MMP-9 null plasma. By mass spectrometry, 34 plasma proteins were significantly different between groups, revealing a previously unappreciated altered baseline environment pre-MI when MMP-9 was deleted. In conclusion, early MMP-9 inhibition delayed inflammation resolution and exacerbated cardiac dysfunction, highlighting the importance of using translational approaches in mice.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Apoptosis; Inhibitor; MMP-9; Macrophage; Myocardial infarction; Neutrophil; Proteomics

Mesh:

Substances:

Year:  2016        PMID: 27746126      PMCID: PMC5319826          DOI: 10.1016/j.yjmcc.2016.10.005

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  45 in total

1.  Proteomic analysis identifies in vivo candidate matrix metalloproteinase-9 substrates in the left ventricle post-myocardial infarction.

Authors:  Rogelio Zamilpa; Elizabeth F Lopez; Ying Ann Chiao; Qiuxia Dai; Gladys P Escobar; Kevin Hakala; Susan T Weintraub; Merry L Lindsey
Journal:  Proteomics       Date:  2010-06       Impact factor: 3.984

2.  MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes.

Authors:  T H Vu; J M Shipley; G Bergers; J E Berger; J A Helms; D Hanahan; S D Shapiro; R M Senior; Z Werb
Journal:  Cell       Date:  1998-05-01       Impact factor: 41.582

3.  Matrix metalloproteinase-28 deletion amplifies inflammatory and extracellular matrix responses to cardiac aging.

Authors:  Yonggang Ma; Ying Ann Chiao; Jianhua Zhang; Anne M Manicone; Yu-Fang Jin; Merry L Lindsey
Journal:  Microsc Microanal       Date:  2011-12-08       Impact factor: 4.127

4.  Early matrix metalloproteinase-12 inhibition worsens post-myocardial infarction cardiac dysfunction by delaying inflammation resolution.

Authors:  Rugmani Padmanabhan Iyer; Nicolle L Patterson; Fouad A Zouein; Yonggang Ma; Vincent Dive; Lisandra E de Castro Brás; Merry L Lindsey
Journal:  Int J Cardiol       Date:  2015-03-05       Impact factor: 4.164

5.  Secreted phosphoprotein 1 (osteopontin) is expressed by stromal macrophages in cyclic and pregnant endometrium of mice, but is induced by estrogen in luminal epithelium during conceptus attachment for implantation.

Authors:  Frankie J White; Robert C Burghardt; Jianbo Hu; Margaret M Joyce; Thomas E Spencer; Greg A Johnson
Journal:  Reproduction       Date:  2006-12       Impact factor: 3.906

6.  Effect of an MMP-9/MMP-12 inhibitor on smoke-induced emphysema and airway remodelling in guinea pigs.

Authors:  Andrew Churg; Rona Wang; Xiaoshan Wang; Per-Ola Onnervik; Kerstin Thim; Joanne L Wright
Journal:  Thorax       Date:  2007-02-20       Impact factor: 9.139

7.  Transgenic overexpression of matrix metalloproteinase-9 in macrophages attenuates the inflammatory response and improves left ventricular function post-myocardial infarction.

Authors:  Rogelio Zamilpa; Jessica Ibarra; Lisandra E de Castro Brás; Trevi A Ramirez; Nguyen Nguyen; Ganesh V Halade; Jianhua Zhang; Qiuxia Dai; Tariq Dayah; Ying Ann Chiao; Wesley Lowell; Seema S Ahuja; Jeanine D'Armiento; Yu-Fang Jin; Merry L Lindsey
Journal:  J Mol Cell Cardiol       Date:  2012-08-03       Impact factor: 5.000

8.  CD36 and TLR interactions in inflammation and phagocytosis: implications for malaria.

Authors:  Laura K Erdman; Gabriela Cosio; Andrew J Helmers; D Channe Gowda; Sergio Grinstein; Kevin C Kain
Journal:  J Immunol       Date:  2009-10-28       Impact factor: 5.422

9.  Reduced BDNF attenuates inflammation and angiogenesis to improve survival and cardiac function following myocardial infarction in mice.

Authors:  Ganesh V Halade; Yonggang Ma; Trevi A Ramirez; Jianhua Zhang; Qiuxia Dai; Julie G Hensler; Elizabeth F Lopez; Omid Ghasemi; Yu-Fang Jin; Merry L Lindsey
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-10-18       Impact factor: 4.733

10.  MetaboAnalyst 3.0--making metabolomics more meaningful.

Authors:  Jianguo Xia; Igor V Sinelnikov; Beomsoo Han; David S Wishart
Journal:  Nucleic Acids Res       Date:  2015-04-20       Impact factor: 16.971

View more
  30 in total

Review 1.  The Role of Inflammation in Cardiovascular Outcome.

Authors:  Fabrizio Montecucco; Luca Liberale; Aldo Bonaventura; Alessandra Vecchiè; Franco Dallegri; Federico Carbone
Journal:  Curr Atheroscler Rep       Date:  2017-03       Impact factor: 5.113

Review 2.  Matrix metalloproteinase collagenolysis in health and disease.

Authors:  Sabrina Amar; Lyndsay Smith; Gregg B Fields
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2017-04-26       Impact factor: 4.739

3.  The compendium of matrix metalloproteinase expression in the left ventricle of mice following myocardial infarction.

Authors:  Amanda R Kaminski; Edwin T Moore; Michael J Daseke; Fritz M Valerio; Elizabeth R Flynn; Merry L Lindsey
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-02-21       Impact factor: 4.733

Review 4.  Proteomic analysis of the cardiac extracellular matrix: clinical research applications.

Authors:  Merry L Lindsey; Mira Jung; Michael E Hall; Kristine Y DeLeon-Pennell
Journal:  Expert Rev Proteomics       Date:  2018-01-09       Impact factor: 3.940

5.  Macrophage overexpression of matrix metalloproteinase-9 in aged mice improves diastolic physiology and cardiac wound healing after myocardial infarction.

Authors:  Cesar A Meschiari; Mira Jung; Rugmani Padmanabhan Iyer; Andriy Yabluchanskiy; Hiroe Toba; Michael R Garrett; Merry L Lindsey
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-10-13       Impact factor: 4.733

6.  Delivery of a matrix metalloproteinase-responsive hydrogel releasing TIMP-3 after myocardial infarction: effects on left ventricular remodeling.

Authors:  Brendan P Purcell; Shayne C Barlow; Paige E Perreault; Lisa Freeburg; Heather Doviak; Julia Jacobs; Abigail Hoenes; Kia N Zellars; Aarif Y Khakoo; TaeWeon Lee; Jason A Burdick; Francis G Spinale
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-07-06       Impact factor: 4.733

Review 7.  Anti-inflammatory therapies in myocardial infarction: failures, hopes and challenges.

Authors:  Shuaibo Huang; Nikolaos G Frangogiannis
Journal:  Br J Pharmacol       Date:  2018-03-04       Impact factor: 8.739

Review 8.  Assigning matrix metalloproteinase roles in ischaemic cardiac remodelling.

Authors:  Merry L Lindsey
Journal:  Nat Rev Cardiol       Date:  2018-08       Impact factor: 32.419

Review 9.  Extracellular matrix roles in cardiorenal fibrosis: Potential therapeutic targets for CVD and CKD in the elderly.

Authors:  Hiroe Toba; Merry L Lindsey
Journal:  Pharmacol Ther       Date:  2018-08-25       Impact factor: 12.310

10.  The Mouse Heart Attack Research Tool 1.0 database.

Authors:  Kristine Y DeLeon-Pennell; Rugmani Padmanabhan Iyer; Yonggang Ma; Andriy Yabluchanskiy; Rogelio Zamilpa; Ying Ann Chiao; Presley L Cannon; Abdullah Kaplan; Courtney A Cates; Elizabeth R Flynn; Ganesh V Halade; Lisandra E de Castro Brás; Merry L Lindsey
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-05-18       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.